Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
Phase 1 Completed
16 enrolled
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
Phase 1 Completed
12 enrolled
REGOMA-2
Phase 1 Completed
21 enrolled
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Phase 1 Completed
17 enrolled
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
Phase 1 Completed
12 enrolled
STEAM
Phase 1 Completed
71 enrolled 18 charts
ASP8374 + Cemiplimab in Recurrent Glioma
Phase 1 Completed
14 enrolled
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma
Phase 1 Completed
21 enrolled 12 charts
Chlorpromazine and Standard of Care in Glioblastoma
Phase 1 Completed
10 enrolled
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Phase 1 Completed
36 enrolled 21 charts
A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
Phase 1 Completed
21 enrolled 36 charts
HUMC 1612: Optune NovoTTF-200A System
Phase 1 Completed
7 enrolled 12 charts
Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma
Phase 1 Completed
22 enrolled
Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma
Phase 1 Completed
5 enrolled
CerebralEDV
Phase 1 Completed
9 enrolled
A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
Phase 1 Completed
36 enrolled
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Phase 1 Completed
17 enrolled 11 charts
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
Phase 1 Completed
40 enrolled 22 charts
Phase I EGFR BATs in Newly Diagnosed Glioblastoma
Phase 1 Completed
16 enrolled
8479217
Phase 1 Completed
6 enrolled 17 charts
Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma
Phase 1 Completed
74 enrolled
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Phase 1 Completed
13 enrolled
A Drug-drug Interaction Study of Avapritinib and Midazolam
Phase 1 Completed
10 enrolled
NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
Phase 1 Completed
12 enrolled
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Completed
29 enrolled
Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma
Phase 1 Completed
19 enrolled
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Phase 1 Completed
22 enrolled
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Phase 1 Completed
68 enrolled
Cancer Stem Cell High-Throughput Drug Screening Study
Phase 1 Completed
9 enrolled
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Phase 1 Completed
8 enrolled 9 charts
A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
Phase 1 Completed
15 enrolled
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Phase 1 Completed
46 enrolled 20 charts
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
Phase 1 Completed
13 enrolled
Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
Phase 1 Completed
17 enrolled
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Phase 1 Completed
271 enrolled
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Phase 1 Completed
24 enrolled
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
Phase 1 Completed
63 enrolled
INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
Phase 1 Completed
65 enrolled
BrTK01
Phase 1 Completed
15 enrolled
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
Phase 1 Completed
15 enrolled
CART-EGFRvIII + Pembrolizumab in GBM
Phase 1 Completed
7 enrolled
Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
Phase 1 Completed
18 enrolled
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Phase 1 Completed
22 enrolled
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Phase 1 Completed
10 enrolled
ATTAC
Phase 1 Completed
42 enrolled
SAS-GKRS
Phase 1 Completed
24 enrolled
BG & TMZ Therapy of Glioblastoma Multiforme
Phase 1 Completed
10 enrolled
A Study to Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients
Phase 1 Completed
18 enrolled
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
Phase 1 Completed
192 enrolled 29 charts